Activation	O
of	O
the	O
interleukin	B-DNA
6	I-DNA
gene	I-DNA
by	O
Mycobacterium	O
tuberculosis	O
or	O
lipopolysaccharide	O
is	O
mediated	O
by	O
nuclear	B-protein
factors	I-protein
NF-IL6	I-protein
and	O
NF-kappa	B-protein
B	I-protein
[	O
published	O
erratum	O
appears	O
in	O
Proc	O
Natl	O
Acad	O
Sci	O
U	O
S	O
A	O
1995	O
Apr	O
11	O
;	O
92	O
(	O
8	O
)	O
:	O
3632	O
]	O

The	O
host	O
response	O
to	O
Mycobacterium	O
tuberculosis	O
includes	O
granuloma	O
formation	O
at	O
sites	O
of	O
infection	O
and	O
systemic	O
symptoms	O
.	O

Cytokines	B-protein
have	O
been	O
identified	O
by	O
immunohistochemistry	O
in	O
granulomas	O
in	O
animal	O
models	O
of	O
bacillus	O
Calmette-Guerin	O
(	O
BCG	O
)	O
infection	O
and	O
are	O
released	O
by	O
mononuclear	B-cell_type
phagocytes	I-cell_type
upon	O
stimulation	O
by	O
mycobacterial	O
proteins	O
.	O

In	O
this	O
regard	O
,	O
the	O
cytokine	B-protein
interleukin	B-protein
6	I-protein
(	O
IL-6	B-protein
)	O
may	O
play	O
a	O
role	O
in	O
the	O
clinical	O
manifestations	O
and	O
pathological	O
events	O
of	O
tuberculosis	O
infection	O
.	O

We	O
have	O
demonstrated	O
that	O
lipoarabinomannan	B-protein
(	O
LAM	B-protein
)	O
from	O
the	O
mycobacterial	O
cell	O
wall	O
,	O
which	O
was	O
virtually	O
devoid	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
stimulated	O
mononuclear	B-cell_type
phagocytes	I-cell_type
to	O
release	O
IL-6	B-protein
in	O
a	O
dose-response	O
manner	O
.	O

LAM	B-protein
and	O
LPS	O
were	O
potent	O
inducers	O
of	O
IL-6	B-DNA
gene	I-DNA
expression	O
in	O
peripheral	B-cell_type
blood	I-cell_type
monocytes	I-cell_type
.	O

Both	O
LAM	B-protein
-and	O
LPS-inducible	B-DNA
IL-6	I-DNA
promoter	I-DNA
activity	O
was	O
localized	O
to	O
a	O
DNA	B-DNA
fragment	I-DNA
,	O
positions	O
-158	B-DNA
to	I-DNA
-49	I-DNA
,	O
by	O
deletion	O
analysis	O
and	O
chloramphenicol	B-protein
acetyltransferase	I-protein
assay	O
.	O

Two	O
nuclear	B-protein
factor	I-protein
NF-IL6	I-protein
(	O
positions	O
-153	B-DNA
to	I-DNA
-145	I-DNA
and	O
-83	O
to	O
-75	O
)	O
and	O
one	O
nuclear	B-DNA
factor	I-DNA
NF-kappa	I-DNA
B	I-DNA
(	I-DNA
positions	I-DNA
-72	I-DNA
to	I-DNA
-63	I-DNA
)	I-DNA
motifs	I-DNA
are	O
present	O
within	O
this	O
fragment	O
.	O

Site-directed	O
mutagenesis	O
of	O
one	O
or	O
more	O
of	O
these	O
motifs	O
within	O
the	O
IL-6	B-protein
promoter	O
demonstrated	O
that	O
each	O
has	O
positive	O
regulatory	O
activity	O
and	O
that	O
they	O
could	O
act	O
in	O
a	O
function-	O
and	O
orientation-independent	O
manner	O
.	O

Deletion	O
of	O
all	O
three	O
elements	O
abolished	O
inducibility	O
of	O
IL-6	B-DNA
promoter	I-DNA
activity	O
by	O
both	O
LAM	B-protein
and	O
LPS	O
.	O

We	O
conclude	O
that	O
the	O
NF-IL6	B-DNA
and	I-DNA
NF-kappa	I-DNA
B	I-DNA
sites	I-DNA
mediate	O
IL-6	B-protein
induction	O
in	O
response	O
to	O
both	O
LPS	O
and	O
LAM	B-protein
,	O
acting	O
as	O
bacterial	B-DNA
or	I-DNA
mycobacterial	I-DNA
response	I-DNA
elements	I-DNA
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

91	NULL
,	NULL
pp	NULL
.	NULL

2225-2229	NULL
,	NULL
March	NULL
1994	NULL
Immunology	NULL
Activation	NULL
of	NULL
the	NULL
interleukin	NULL
6	NULL
gene	NULL
by	NULL
Mycobacterium	NULL
tuberculosis	NULL
or	NULL
lipopolysaccharide	NULL
is	NULL
mediated	NULL
by	NULL
nuclear	NULL
factors	NULL
NF-IL6	NULL
and	NULL
Zxancg	NULL
,	NULL
Minpy	NULL
BROSER	NULL
,	NULL
AND	NULL
WILLIAM	NULL
N.	NULL
Rom*	NULL
Division	NULL
of	NULL
Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Medicine	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
York	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
550	NULL
First	NULL
Avenue	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10016	NULL
Communicated	NULL
by	NULL
H.	NULL
Sherwood	NULL
Lawrence	NULL
,	NULL
July	NULL
21	NULL
,	NULL
1993	NULL
(	NULL
received	NULL
for	NULL
review	NULL
December	NULL
23	NULL
,	NULL
1992	NULL
)	NULL
ABSTRACT	NULL
The	NULL
host	NULL
response	NULL
to	NULL
Mycobacterium	NULL
tuberculosis	NULL
includes	NULL
granuloma	NULL
formation	NULL
at	NULL
sites	NULL
of	NULL
infection	NULL
and	NULL
systemic	NULL
symptoms	NULL
.	NULL

Cytokines	NULL
have	NULL
been	NULL
identified	NULL
by	NULL
immu-nohistochemistry	NULL
in	NULL
granulomas	NULL
in	NULL
animal	NULL
models	NULL
of	NULL
bacillus	NULL
Calmette-Guérin	NULL
(	NULL
BCG	NULL
)	NULL
infection	NULL
and	NULL
are	NULL
released	NULL
by	NULL
mononuclear	NULL
phagocytes	NULL
upon	NULL
stimulation	NULL
by	NULL
mycobacterial	NULL
pro-teins	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
cytokine	NULL
interleukin	NULL
6	NULL
(	NULL
IL-6	NULL
)	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
clinical	NULL
manifestations	NULL
and	NULL
pathological	NULL
events	NULL
of	NULL
tuberculosis	NULL
infection	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
lipoarabi-nomannan	NULL
(	NULL
LAM	NULL
)	NULL
from	NULL
the	NULL
mycobacterial	NULL
cell	NULL
wall	NULL
,	NULL
which	NULL
was	NULL
virtually	NULL
devoid	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
stimulated	NULL
mononuclear	NULL
phagocytes	NULL
to	NULL
release	NULL
IL-6	NULL
in	NULL
a	NULL
dose-response	NULL
manner	NULL
.	NULL

LAM	NULL
and	NULL
LPS	NULL
were	NULL
potent	NULL
inducers	NULL
of	NULL
IL-6	NULL
gene	NULL
expression	NULL
in	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

Both	NULL
LAM-	NULL
and	NULL
LPS-inducible	NULL
IL-6	NULL
promoter	NULL
activity	NULL
was	NULL
localized	NULL
to	NULL
a	NULL
DNA	NULL
fragment	NULL
,	NULL
positions	NULL
-158	NULL
to	NULL
-49	NULL
,	NULL
by	NULL
deletion	NULL
analysis	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
assay	NULL
.	NULL

Two	NULL
nuclear	NULL
factor	NULL
NF-IL6	NULL
(	NULL
positions	NULL
-153	NULL
to	NULL
-145	NULL
and	NULL
-83	NULL
to	NULL
-75	NULL
)	NULL
and	NULL
one	NULL
nuclear	NULL
factor	NULL
NF-xB	NULL
(	NULL
positions	NULL
-72	NULL
to	NULL
-63	NULL
)	NULL
motifs	NULL
are	NULL
present	NULL
within	NULL
this	NULL
fragment	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
motifs	NULL
within	NULL
the	NULL
IL-6	NULL
promoter	NULL
demonstrated	NULL
that	NULL
each	NULL
has	NULL
positive	NULL
regulatory	NULL
activity	NULL
and	NULL
that	NULL
they	NULL
could	NULL
act	NULL
in	NULL
a	NULL
func-tion-	NULL
and	NULL
orientation-independent	NULL
manner	NULL
.	NULL

Deletion	NULL
of	NULL
all	NULL
three	NULL
elements	NULL
abolished	NULL
inducibility	NULL
of	NULL
IL-6	NULL
promoter	NULL
activity	NULL
by	NULL
both	NULL
LAM	NULL
and	NULL
LPS	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
NF-IL6	NULL
and	NULL
NF-xB	NULL
sites	NULL
mediate	NULL
IL-6	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
both	NULL
LPS	NULL
and	NULL
LAM	NULL
,	NULL
acting	NULL
as	NULL
bacterial	NULL
or	NULL
mycobacterial	NULL
response	NULL
elements	NULL
.	NULL

The	NULL
variety	NULL
of	NULL
human	NULL
cell-mediated	NULL
immune	NULL
defenses	NULL
against	NULL
Mycobacterium	NULL
tuberculosis	NULL
is	NULL
reflected	NULL
in	NULL
the	NULL
wide	NULL
range	NULL
of	NULL
clinical	NULL
manifestations	NULL
of	NULL
active	NULL
disease	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Ineffective	NULL
cellular	NULL
immunity	NULL
results	NULL
in	NULL
the	NULL
failure	NULL
of	NULL
localization	NULL
of	NULL
M.	NULL
tuberculosis	NULL
infection	NULL
with	NULL
absence	NULL
of	NULL
granuloma	NULL
formation	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
interleukin	NULL
18	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
and	NULL
interferon	NULL
y	NULL
are	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
part	NULL
in	NULL
human	NULL
cell-mediated	NULL
immune	NULL
response	NULL
to	NULL
infection	NULL
with	NULL
many	NULL
facultative	NULL
intracellular	NULL
pathogens	NULL
,	NULL
including	NULL
Listeria	NULL
monocytogenes	NULL
,	NULL
Leish-mania	NULL
,	NULL
Candida	NULL
,	NULL
and	NULL
mycobacteria	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

TNF-a	NULL
is	NULL
also	NULL
required	NULL
for	NULL
localization	NULL
of	NULL
mycobacterial	NULL
infection	NULL
and	NULL
granuloma	NULL
formation	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Interleukin	NULL
6	NULL
(	NULL
IL-6	NULL
)	NULL
is	NULL
a	NULL
multifunc-tional	NULL
cytokine	NULL
regulating	NULL
immune	NULL
responses	NULL
and	NULL
the	NULL
acute-phase	NULL
protein	NULL
response	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

In	NULL
active	NULL
tuberculosis	NULL
,	NULL
the	NULL
role	NULL
of	NULL
IL-6	NULL
may	NULL
be	NULL
predominantly	NULL
negative	NULL
.	NULL

This	NULL
is	NULL
supported	NULL
by	NULL
several	NULL
facts	NULL
:	NULL
(	NULL
?	NULL
)	NULL

IL-6	NULL
promotes	NULL
the	NULL
growth	NULL
of	NULL
mycobacteria	NULL
in	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

(	NULL
i	NULL
?	NULL
)	NULL

IL-6	NULL
inhibits	NULL
the	NULL
production	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-18B	NULL
,	NULL
which	NULL
may	NULL
enhance	NULL
intracellular	NULL
killing	NULL
of	NULL
microorganisms	NULL
and	NULL
development	NULL
of	NULL
gran-ulomata	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

M.	NULL
tuberculosis	NULL
components	NULL
stimulate	NULL
the	NULL
release	NULL
of	NULL
both	NULL
IL-18	NULL
and	NULL
TNF-a	NULL
from	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
16-21	NULL
)	NULL
.	NULL

TNF-a	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
accumulate	NULL
in	NULL
granulomas	NULL
of	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

2225	NULL
experimental	NULL
models	NULL
of	NULL
tuberculosis	NULL
infection	NULL
,	NULL
and	NULL
pretreat-ment	NULL
with	NULL
anti-TNF-a	NULL
antibody	NULL
results	NULL
in	NULL
poorly	NULL
formed	NULL
granulomas	NULL
,	NULL
dissemination	NULL
of	NULL
the	NULL
mycobacteria	NULL
,	NULL
and	NULL
death	NULL
of	NULL
the	NULL
animal	NULL
(	NULL
8	NULL
)	NULL
.	NULL

TNF-a	NULL
and	NULL
IL-1	NULL
$	NULL
induce	NULL
IL-6	NULL
in	NULL
human	NULL
fibroblasts	NULL
by	NULL
activating	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
a	NULL
NF-	NULL
«	NULL
B-like	NULL
sequence	NULL
(	NULL
22	NULL
)	NULL
.	NULL

IL-6	NULL
may	NULL
be	NULL
a	NULL
negative	NULL
modulator	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
in	NULL
active	NULL
tuberculosis	NULL
favoring	NULL
dissemination	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus-infected	NULL
individuals	NULL
,	NULL
hypergammaglobulinemia	NULL
and	NULL
expansion	NULL
of	NULL
B	NULL
cells	NULL
may	NULL
be	NULL
likely	NULL
a	NULL
result	NULL
of	NULL
IL-6	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Tuberculosis	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus-infected	NULL
individuals	NULL
takes	NULL
on	NULL
a	NULL
more	NULL
aggressive	NULL
course	NULL
with	NULL
dense	NULL
aggregates	NULL
of	NULL
organisms	NULL
in	NULL
infected	NULL
tissue	NULL
,	NULL
poorly	NULL
formed	NULL
and	NULL
fewer	NULL
granulomata	NULL
,	NULL
and	NULL
more	NULL
frequent	NULL
miliary	NULL
presentation	NULL
(	NULL
24-26	NULL
)	NULL
.	NULL

Alveolar	NULL
macrophages	NULL
phagocytose	NULL
mycobacteria	NULL
but	NULL
have	NULL
difficulty	NULL
with	NULL
intracellular	NULL
killing	NULL
.	NULL

The	NULL
cell	NULL
wall	NULL
of	NULL
mycobacteria	NULL
does	NULL
not	NULL
contain	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
well	NULL
known	NULL
inducer	NULL
of	NULL
IL-6	NULL
.	NULL

However	NULL
,	NULL
lipoarab-inomannan	NULL
(	NULL
LAM	NULL
)	NULL
,	NULL
a	NULL
complex	NULL
lipid	NULL
glycoprotein	NULL
anchored	NULL
in	NULL
the	NULL
cell	NULL
membrane	NULL
by	NULL
phosphatidylinositol	NULL
,	NULL
shares	NULL
many	NULL
physicochemical	NULL
properties	NULL
with	NULL
LPS	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
purified	NULL
LAM	NULL
,	NULL
virtually	NULL
devoid	NULL
of	NULL
LPS	NULL
contamina-tion	NULL
,	NULL
could	NULL
induce	NULL
the	NULL
production	NULL
of	NULL
IL-6	NULL
,	NULL
we	NULL
measured	NULL
IL-6	NULL
protein	NULL
and	NULL
mRNA	NULL
levels	NULL
after	NULL
exposure	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
to	NULL
LAM	NULL
.	NULL

Not	NULL
only	NULL
was	NULL
IL-6	NULL
protein	NULL
and	NULL
mRNA	NULL
increased	NULL
but	NULL
also	NULL
IL-6	NULL
promoter	NULL
activity	NULL
was	NULL
markedly	NULL
enhanced	NULL
by	NULL
LAM	NULL
or	NULL
LPS	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
LAM	NULL
from	NULL
laboratory-attenuated	NULL
M.	NULL
tuberculosis	NULL
H37Ra	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
P.	NULL
Brennan	NULL
(	NULL
Colorado	NULL
State	NULL
Univer-sity	NULL
,	NULL
Ft.	NULL
Collins	NULL
)	NULL
.	NULL

The	NULL
LAM	NULL
had	NULL
been	NULL
passed	NULL
through	NULL
a	NULL
Detoxi-Gel	NULL
column	NULL
using	NULL
sterile	NULL
pyrogen-free	NULL
water	NULL
and	NULL
stored	NULL
in	NULL
pyrogen-free	NULL
vials	NULL
from	NULL
which	NULL
any	NULL
contaminating	NULL
LPS	NULL
had	NULL
been	NULL
removed	NULL
.	NULL

Only	NULL
pyrogen-free	NULL
water	NULL
was	NULL
used	NULL
in	NULL
reconstitution	NULL
of	NULL
this	NULL
material	NULL
.	NULL

Evaluation	NULL
of	NULL
tuberculosis	NULL
reagents	NULL
including	NULL
LAM	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
Gram-negative	NULL
bacterial	NULL
endotoxin	NULL
was	NULL
done	NULL
with	NULL
the	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
E-toxate	NULL
kit	NULL
,	NULL
Sigma	NULL
)	NULL
.	NULL

Six	NULL
lots	NULL
of	NULL
LAM	NULL
obtained	NULL
between	NULL
1990	NULL
to	NULL
1993	NULL
contained	NULL
<	NULL
10	NULL
pg	NULL
of	NULL
LPS	NULL
per	NULL
ug	NULL
of	NULL
LAM	NULL
per	NULL
batch	NULL
.	NULL

Isolation	NULL
of	NULL
Human	NULL
Monocytes	NULL
from	NULL
Peripheral	NULL
Blood	NULL
.	NULL

Mononuclear	NULL
cells	NULL
in	NULL
peripheral	NULL
blood	NULL
from	NULL
purified-protein-derivative-negative	NULL
donors	NULL
were	NULL
separated	NULL
by	NULL
centrifugation	NULL
over	NULL
lymphocyte-separation	NULL
medium	NULL
(	NULL
Flow	NULL
Laboratories	NULL
)	NULL
.	NULL

Abbreviations	NULL
:	NULL
IL-6	NULL
,	NULL
interleukin	NULL
6	NULL
;	NULL
LAM	NULL
,	NULL
lipoarabinomannan	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
;	NULL
IL-18	NULL
,	NULL
inter	NULL
{	NULL
pukin	NULL
18	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltrans-erase	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Division	NULL
of	NULL
Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Medicine	NULL
,	NULL
Bellevue	NULL
Hospital	NULL
Center	NULL
,	NULL
Room	NULL
7N24	NULL
,	NULL
New	NULL
York	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
550	NULL
First	NULL
Avenue	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10016	NULL
.	NULL

2226	NULL
Immunology	NULL
:	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
seeded	NULL
onto	NULL
the	NULL
plastic	NULL
surface	NULL
of	NULL
a	NULL
flask	NULL
to	NULL
allow	NULL
monocytes	NULL
to	NULL
adhere	NULL
.	NULL

Human	NULL
myelomonocytic	NULL
leukemic	NULL
cell	NULL
line	NULL
THP-1	NULL
(	NULL
ATCC	NULL
)	NULL
or	NULL
the	NULL
isolated	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
fetal	NULL
bovine	NULL
se-rum	NULL
.	NULL

IL-6	NULL
protein	NULL
levels	NULL
in	NULL
cell	NULL
supernatants	NULL
were	NULL
measured	NULL
with	NULL
a	NULL
commercial	NULL
ELISA	NULL
kit	NULL
(	NULL
Biokine	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
RNA	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
test	NULL
reagents	NULL
,	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
lysed	NULL
by	NULL
addition	NULL
of	NULL
5.5	NULL
M	NULL
guanidinium	NULL
isothiocyanate	NULL
buffer	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
through	NULL
CsCl	NULL
;	NULL
gradient	NULL
ultracentrifugation	NULL
.	NULL

An	NULL
equal	NULL
amount	NULL
of	NULL
RNA	NULL
was	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
through	NULL
a	NULL
1	NULL
%	NULL
agarose/6	NULL
%	NULL
formaldehyde	NULL
denaturing	NULL
gel	NULL
and	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
(	NULL
BA	NULL
85	NULL
,	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

The	NULL
baked	NULL
filter	NULL
was	NULL
prehybridized	NULL
at	NULL
42°C	NULL
for	NULL
6-12	NULL
hr	NULL
.	NULL

For	NULL
hybridization	NULL
,	NULL
the	NULL
IL-6	NULL
cDNA	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
J.	NULL
Vilcek	NULL
,	NULL
New	NULL
York	NULL
University	NULL
)	NULL
was	NULL
nick-translated	NULL
with	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
dCTP	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
1	NULL
Ci	NULL
=	NULL
37	NULL
GBq	NULL
;	NULL
New	NULL
England	NULL
Nuclear	NULL
)	NULL
.	NULL

The	NULL
hybridization	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
42°C	NULL
for	NULL
10	NULL
hr	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
then	NULL
washed	NULL
in	NULL
2	NULL
%	NULL
standard	NULL
saline	NULL
citrate	NULL
(	NULL
SSC	NULL
)	NULL
/0.5	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
followed	NULL
by	NULL
0.1x	NULL
SSC/0.5	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
then	NULL
exposed	NULL
to	NULL
film	NULL
at	NULL
-70°C	NULL
.	NULL

Plasmid	NULL
Construction	NULL
and	NULL
Site-Directed	NULL
Mutagenesis	NULL
.	NULL

Serial	NULL
deletion	NULL
mutant	NULL
constructs	NULL
of	NULL
IL-6	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
were	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
was	NULL
carried	NULL
out	NULL
according	NULL
to	NULL
directions	NULL
in	NULL
the	NULL
Bio-Rad	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
.	NULL

The	NULL
mutant	NULL
oligonucleotides	NULL
synthesized	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
NF-IL6	NULL
(	NULL
positions	NULL
-153	NULL
to	NULL
-145	NULL
)	NULL
to	NULL
5-CCGTACAAT-3	NULL
'	NULL
,	NULL
NF-IL6	NULL
(	NULL
positions	NULL
-83	NULL
to	NULL
-75	NULL
)	NULL
to	NULL
5	NULL
!	NULL

-CCATAAAAT-3	NULL
'	NULL
,	NULL
and	NULL
NF-KB	NULL
(	NULL
positions	NULL
-72	NULL
to	NULL
-63	NULL
)	NULL
to	NULL
5-CTCATTTTCC-3	NULL
'	NULL
.	NULL

The	NULL
IL-6	NULL
fragment	NULL
,	NULL
positions	NULL
-224	NULL
to	NULL
+11	NULL
,	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
.	NULL

The	NULL
achieved	NULL
mutant	NULL
IL-6	NULL
DNA	NULL
sequences	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Seven	NULL
single	NULL
or	NULL
combined	NULL
mutations	NULL
were	NULL
obtained	NULL
:	NULL
single	NULL
NF-IL6	NULL
site	NULL
mutation	NULL
,	NULL
double	NULL
NF-IL6	NULL
site	NULL
mutations	NULL
,	NULL
a	NULL
combined	NULL
NF-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
\site	NULL
mutation	NULL
,	NULL
and	NULL
triple	NULL
(	NULL
two	NULL
NF-IL6	NULL
and	NULL
one	NULL
NF-KB	NULL
sites	NULL
)	NULL
mutations	NULL
.	NULL

Transient	NULL
Transfection	NULL
of	NULL
Human	NULL
Suspension	NULL
Cultures	NULL
and	NULL
the	NULL
Assay	NULL
of	NULL
Chloramphenicol	NULL
Acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
Activ-ity	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
various	NULL
IL-6	NULL
DNA	NULL
constructs	NULL
in	NULL
the	NULL
plasmid	NULL
pTK	NULL
(	NULL
-	NULL
)	NULL
CAT	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
STBS	NULL
(	NULL
25	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4/137	NULL
mM	NULL
NaCl/5	NULL
mM	NULL
KCI/0.6	NULL
mM	NULL
Na	NULL
;	NULL
HPO	NULL
,	NULL
/	NULL
0.7	NULL
mM	NULL
CaC1	NULL
,	NULL
/0.5	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
)	NULL
,	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
CsCl	NULL
,	NULL
-purified	NULL
plasmids	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
400	NULL
ug/ml	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
90	NULL
min	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
complete	NULL
medium	NULL
for	NULL
24	NULL
hr	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
inducing	NULL
agents	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
three	NULL
freeze-thaw	NULL
cycles	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
different	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
and	NULL
DNA	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
THP-1	NULL
cells	NULL
by	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
.	NULL

Cultures	NULL
(	NULL
5	NULL
x	NULL
108	NULL
cells	NULL
)	NULL
were	NULL
lysed	NULL
by	NULL
homogenization	NULL
in	NULL
buffer	NULL
A	NULL
[	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9/1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
/10	NULL
mM	NULL
KCI/O0.5	NULL
mM	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
/0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
]	NULL
and	NULL
centrifuged	NULL
at	NULL
1000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
to	NULL
separate	NULL
the	NULL
nuclei	NULL
from	NULL
the	NULL
cytosolic	NULL
fraction	NULL
.	NULL

The	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
in	NULL
buffer	NULL
C	NULL
[	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9/25	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol/0.42	NULL
M	NULL
NaCl/1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
/0.2	NULL
mM	NULL
EDTA/O.5	NULL
mM	NULL
DTT/0.5	NULL
mM	NULL
phenyImethyisuilfony	NULL
}	NULL
fluoride	NULL
]	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
with	NULL
shaking	NULL
.	NULL

The	NULL
extracted	NULL
nuclear	NULL
proteins	NULL
were	NULL
dialyzed	NULL
against	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9/20	NULL
%	NULL
glycero	NULL
!	NULL

/0.1	NULL
M	NULL
KCI/0.2	NULL
mM	NULL
EDTA/O0.5	NULL
mM	NULL
DTT/O0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
for	NULL
5	NULL
hr	NULL
and	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
in	NULL
aliquots	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
Sen	NULL
and	NULL
Baltimore	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
probes	NULL
were	NULL
end-labeled	NULL
by	NULL
using	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
100	NULL
uCi	NULL
of	NULL
[	NULL
y*°P	NULL
]	NULL
ATP	NULL
.	NULL

Probes	NULL
(	NULL
10,000	NULL
cpm	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
cell	NULL
extracts	NULL
under	NULL
the	NULL
binding	NULL
conditions	NULL
[	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5/50	NULL
mM	NULL
NaCl/1	NULL
mM	NULL
EDTA/O.1	NULL
mM	NULL
DTT/2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
/10	NULL
%	NULL
glycerol	NULL
]	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
wl	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
products	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
Mycobacterial	NULL
Cell	NULL
Wall	NULL
Component	NULL
LAM	NULL
Stimulates	NULL
the	NULL
Release	NULL
of	NULL
IL-6	NULL
Protein	NULL
and	NULL
Expression	NULL
of	NULL
IL-6	NULL
mRNA	NULL
from	NULL
Peripheral	NULL
Blood	NULL
Monocytes	NULL
.	NULL

Monocytes	NULL
released	NULL
a	NULL
significant	NULL
amount	NULL
of	NULL
IL-6	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LAM	NULL
at	NULL
0.1	NULL
ng/ml	NULL
over	NULL
a	NULL
24-hr	NULL
period	NULL
with	NULL
a	NULL
maximal	NULL
response	NULL
at	NULL
2	NULL
ug/ml	NULL
!	NULL

(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
half-maximal	NULL
effect	NULL
occurred	NULL
at	NULL
500	NULL
ng/ml	NULL
(	NULL
EDsp	NULL
)	NULL
,	NULL
which	NULL
was	NULL
chosen	NULL
as	NULL
the	NULL
dose	NULL
for	NULL
subsequent	NULL
experiments	NULL
.	NULL

Live	NULL
M.	NULL
tuberculosis	NULL
H37Ra	NULL
and	NULL
a	NULL
clinical	NULL
isolate	NULL
of	NULL
M.	NULL
tuberculosis	NULL
exhibited	NULL
a	NULL
parallel	NULL
dose-response	NULL
stimulation	NULL
of	NULL
IL-6	NULL
release	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
LAM	NULL
was	NULL
not	NULL
due	NULL
to	NULL
contamination	NULL
by	NULL
LPS	NULL
because	NULL
the	NULL
LPS	NULL
content	NULL
in	NULL
1	NULL
ug	NULL
of	NULL
LAM	NULL
was	NULL
<	NULL
10	NULL
pg	NULL
in	NULL
all	NULL
LAM	NULL
aliquots	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
Limulus	NULL
amebocyte	NULL
assay	NULL
,	NULL
and	NULL
LPS	NULL
at	NULL
10	NULL
pg/ml	NULL
could	NULL
not	NULL
stimulate	NULL
the	NULL
production	NULL
of	NULL
IL-6	NULL
as	NULL
detected	NULL
by	NULL
ELISA	NULL
.	NULL

Polymyxin	NULL
B	NULL
at	NULL
10	NULL
ug/ml	NULL
inhibited	NULL
the	NULL
LPS	NULL
effect	NULL
,	NULL
whereas	NULL
it	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
LAM	NULL
to	NULL
stimulate	NULL
IL-6	NULL
release	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
increased	NULL
release	NULL
of	NULL
IL-6	NULL
protein	NULL
was	NULL
in	NULL
parallel	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
IL-6	NULL
mRNA	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
levels	NULL
of	NULL
IL-6	NULL
mRNA	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
we	NULL
used	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
the	NULL
human	NULL
myelomonocytic	NULL
leukemic	NULL
cell	NULL
line	NULL
THP-1	NULL
,	NULL
which	NULL
was	NULL
used	NULL
for	NULL
transient	NULL
transfection	NULL
experiments	NULL
shown	NULL
later	NULL
.	NULL

The	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
were	NULL
significantly	NULL
increased	NULL
in	NULL
blood	NULL
monocytes	NULL
and	NULL
THP-1	NULL
cells	NULL
after	NULL
stimulation	NULL
with	NULL
LAM	NULL
or	NULL
LPS	NULL
for	NULL
4	NULL
hr	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
C	NULL
and	NULL
D	NULL
demonstrates	NULL
equal	NULL
amounts	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
(	NULL
ethidium	NULL
bromide-stained	NULL
gels	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
the	NULL
increased	NULL
IL-6	NULL
mRNA	NULL
level	NULL
contributes	NULL
to	NULL
the	NULL
enhanced	NULL
release	NULL
of	NULL
IL-6	NULL
protein	NULL
detected	NULL
in	NULL
the	NULL
cell	NULL
culture	NULL
supernatants	NULL
.	NULL

24	NULL
21	NULL
18	NULL
15	NULL
12	NULL
Interleukin-6	NULL
(	NULL
pg/m	NULL
!	NULL

l	NULL
x	NULL
107°	NULL
)	NULL
ip	NULL
unl	NULL
1.0	NULL
mg	NULL
i	NULL
1.0	NULL
ng	NULL
1.0	NULL
ug	NULL
L	NULL
i	NULL
5x10	NULL
%	NULL
5x10°	NULL
Sx10°	NULL
Mtb	NULL
.	NULL

Dose	NULL
cg	NULL
p	NULL
ruiul	NULL
0	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

Release	NULL
of	NULL
IL-6	NULL
from	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
after	NULL
stimulation	NULL
with	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
live	NULL
M.	NULL
tuberculosis	NULL
(	NULL
M.tb	NULL
.	NULL
)	NULL

H37Ra	NULL
.	NULL

0	NULL
,	NULL
LPS	NULL
;	NULL
@	NULL
,	NULL
LAM	NULL
;	NULL
m	NULL
,	NULL
M.	NULL
tuberculosis	NULL
H37Ra	NULL
.	NULL

Immunology	NULL
:	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

A	NULL
_	NULL
THP-1	NULL
B	NULL
PBM	NULL
C	NULL
Lam	NULL
LPs	NULL
C	NULL
LAMLPS	NULL
1.3kb	NULL
-	NULL
»	NULL
~	NULL
130	NULL
-	NULL
-	NULL
SBK	NULL
C	NULL
D	NULL
FiG	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
IL-6	NULL
mRNA	NULL
in	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
B	NULL
)	NULL
and	NULL
THP-1	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
after	NULL
LAM	NULL
or	NULL
LPS	NULL
stimulation	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
or	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
hr	NULL
with	NULL
or	NULL
without	NULL
stimuli	NULL
(	NULL
LAM	NULL
at	NULL
500	NULL
ng/ml	NULL
or	NULL
LPS	NULL
at	NULL
500	NULL
ng/ml	NULL
)	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Ethidium	NULL
bromide-stained	NULL
gels	NULL
demonstrating	NULL
equal	NULL
amounts	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

Lanes	NULL
C	NULL
,	NULL
control	NULL
.	NULL

Regulation	NULL
of	NULL
IL-6	NULL
Gene	NULL
Transcription	NULL
by	NULL
LAM	NULL
and	NULL
LPS	NULL
in	NULL
THP-1	NULL
Cells	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
is	NULL
regulated	NULL
upon	NULL
exposure	NULL
to	NULL
M.	NULL
tuberculosis	NULL
,	NULL
we	NULL
mapped	NULL
DNA	NULL
regulatory	NULL
elements	NULL
on	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
that	NULL
responded	NULL
to	NULL
LAM	NULL
and	NULL
compared	NULL
them	NULL
with	NULL
LPS	NULL
,	NULL
a	NULL
well	NULL
known	NULL
inducer	NULL
of	NULL
IL-6	NULL
.	NULL

Serial	NULL
IL-6	NULL
deletion	NULL
mutant	NULL
constructs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
,	NULL
and	NULL
CAT	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
schematic	NULL
of	NULL
IL-6	NULL
promoter	NULL
elements	NULL
and	NULL
deletion	NULL
mu-tants	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
induced	NULL
with	NULL
the	NULL
IL-6	NULL
construct	NULL
,	NULL
positions	NULL
-1158	NULL
to	NULL
+11	NULL
,	NULL
after	NULL
stimulation	NULL
with	NULL
LAM	NULL
or	NULL
LPS	NULL
AP-1	NULL
|	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
2227	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

There	NULL
was	NULL
increased	NULL
CAT	NULL
activity	NULL
after	NULL
stimulation	NULL
by	NULL
LAM	NULL
or	NULL
LPS	NULL
with	NULL
the	NULL
constructs	NULL
,	NULL
positions	NULL
-224	NULL
to	NULL
+11	NULL
,	NULL
positions	NULL
-158	NULL
to	NULL
+11	NULL
,	NULL
and	NULL
positions	NULL
-109	NULL
to	NULL
+11	NULL
.	NULL

Further	NULL
deletion	NULL
to	NULL
position	NULL
-49	NULL
totally	NULL
abolished	NULL
the	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
after	NULL
stimulation	NULL
with	NULL
LAM	NULL
or	NULL
LPS	NULL
.	NULL

Sequence	NULL
analysis	NULL
demonstrated	NULL
that	NULL
deletion	NULL
from	NULL
positions	NULL
-158	NULL
to	NULL
-109	NULL
resulted	NULL
in	NULL
removal	NULL
of	NULL
a	NULL
NF-IL6	NULL
binding	NULL
site	NULL
(	NULL
positions	NULL
-153	NULL
to	NULL
-145	NULL
)	NULL
,	NULL
and	NULL
further	NULL
deletion	NULL
to	NULL
position	NULL
-49	NULL
led	NULL
to	NULL
removal	NULL
of	NULL
another	NULL
NF-IL6	NULL
binding	NULL
site	NULL
(	NULL
positions	NULL
-83	NULL
to	NULL
-75	NULL
)	NULL
and	NULL
a	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
(	NULL
positions	NULL
-72	NULL
to	NULL
-63	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
NF-IL6	NULL
[	NULL
consensus	NULL
sequence	NULL
,	NULL
T	NULL
(	NULL
T/	NULL
G	NULL
)	NULL
NNGNAA	NULL
(	NULL
T/G	NULL
)	NULL
]	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequences	NULL
contribute	NULL
to	NULL
the	NULL
stimulatory	NULL
activities	NULL
by	NULL
LAM	NULL
or	NULL
LPS	NULL
,	NULL
we	NULL
performed	NULL
site-directed	NULL
mutagenesis	NULL
on	NULL
the	NULL
IL-6	NULL
DNA	NULL
fragment	NULL
from	NULL
positions	NULL
-224	NULL
to	NULL
+11	NULL
,	NULL
in	NULL
which	NULL
seven	NULL
mutation	NULL
constructs	NULL
were	NULL
made	NULL
and	NULL
tested	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
LAM	NULL
or	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
produced	NULL
with	NULL
the	NULL
.	NULL

wild-type	NULL
fragment	NULL
from	NULL
positions	NULL
-224	NULL
to	NULL
+11	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
5	NULL
NF-IL6	NULL
site	NULL
with	NULL
intact	NULL
3	NULL
'	NULL
NF-IL6	NULL
and	NULL
NF-KB	NULL
sites	NULL
resulted	NULL
in	NULL
inducible	NULL
CAT	NULL
activity	NULL
that	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
unmutated	NULL
construct	NULL
.	NULL

With	NULL
a	NULL
mutation	NULL
of	NULL
the	NULL
3°	NULL
NF-IL6	NULL
site	NULL
alone	NULL
or	NULL
after	NULL
a	NULL
single	NULL
mutation	NULL
of	NULL
the	NULL
NF-KB	NULL
site	NULL
,	NULL
IL-6	NULL
promoter	NULL
activity	NULL
was	NULL
still	NULL
inducible	NULL
by	NULL
LAM	NULL
or	NULL
LPS	NULL
,	NULL
albeit	NULL
at	NULL
a	NULL
somewhat	NULL
reduced	NULL
level	NULL
.	NULL

Mutation	NULL
of	NULL
two	NULL
of	NULL
the	NULL
three	NULL
sites	NULL
showed	NULL
inducibility	NULL
to	NULL
be	NULL
S-fold	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
intact	NULL
,	NULL
4-fold	NULL
with	NULL
3	NULL
'	NULL
NF-IL6	NULL
intact	NULL
,	NULL
and	NULL
3-fold	NULL
with	NULL
5	NULL
NF-IL6	NULL
intact	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
from	NULL
the	NULL
construct	NULL
with	NULL
the	NULL
3°	NULL
NF-IL6	NULL
intact	NULL
was	NULL
3.8	NULL
and	NULL
3.7	NULL
,	NULL
respectively	NULL
,	NULL
after	NULL
stimulation	NULL
with	NULL
LAM	NULL
and	NULL
LPS	NULL
,	NULL
which	NULL
was	NULL
notably	NULL
greater	NULL
than	NULL
the	NULL
2.9-	NULL
and	NULL
2.7-fold	NULL
increase	NULL
seen	NULL
with	NULL
the	NULL
construct	NULL
with	NULL
only	NULL
the	NULL
5°	NULL
NF-IL6	NULL
intact	NULL
.	NULL

Mutation	NULL
of	NULL
all	NULL
three	NULL
nuclear	NULL
binding	NULL
elements	NULL
abolished	NULL
activation	NULL
of	NULL
IL-6	NULL
promoter	NULL
activity	NULL
by	NULL
LAM	NULL
or	NULL
LPS	NULL
.	NULL

These	NULL
experiments	NULL
suggested	NULL
that	NULL
the	NULL
two	NULL
NF-IL6	NULL
sites	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
on	NULL
the	NULL
IL-6	NULL
gene	NULL
functioned	NULL
as	NULL
positive	NULL
regulatory	NULL
sequences	NULL
in	NULL
response	NULL
to	NULL
the	NULL
induction	NULL
with	NULL
LAM	NULL
or	NULL
LPS	NULL
.	NULL

Each	NULL
site	NULL
can	NULL
function	NULL
in	NULL
an	NULL
independent	NULL
manner	NULL
after	NULL
mutation	NULL
of	NULL
the	NULL
other	NULL
two	NULL
sites	NULL
,	NULL
but	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
each	NULL
of	NULL
the	NULL
three	NULL
elements	NULL
is	NULL
different	NULL
.	NULL

LAM	NULL
and	NULL
LPS	NULL
Stimulate	NULL
Interaction	NULL
Between	NULL
Nuclear	NULL
Protein	NULL
(	NULL
s	NULL
)	NULL
and	NULL
NF-IL6	NULL
or	NULL
NF-xB	NULL
Sequences	NULL
.	NULL

The	NULL
deletion	NULL
analysis	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
experiments	NULL
described	NULL
above	NULL
suggest	NULL
that	NULL
the	NULL
NF-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
are	NULL
the	NULL
positive	NULL
regulatory	NULL
elements	NULL
for	NULL
LAM	NULL
or	NULL
LPS	NULL
stimulation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
these	NULL
sequences	NULL
interact	NULL
specifically	NULL
with	NULL
nuclear	NULL
proteins	NULL
,	NULL
DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
.	NULL

Incubation	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
LAM-	NULL
or	NULL
LPS-stimulated	NULL
cells	NULL
with	NULL
the	NULL
5	NULL
'	NULL
NF-IL6	NULL
probe	NULL
led	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
protein-DNA	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
the	NULL
complexes	NULL
demonstrated	NULL
by	NULL
DNA	NULL
CRE	NULL
AP-2	NULL
NF-xB	NULL
_	NULL
TATA	NULL
an	NULL
-224	NULL
-158	NULL
1	NULL
/\	NULL
L_____	NULL
NF	NULL
IL-6	NULL
-|-	NULL
+11	NULL
-+-	NULL
+11	NULL
109	NULL
.	NULL

--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-o411	NULL
-49	NULL
0	NULL
--	NULL
--	NULL
--	NULL
-f	NULL
--	NULL
o	NULL
411	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Schematic	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
and	NULL
deletion	NULL
analysis	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
.	NULL

2228	NULL
Immunology	NULL
:	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

0	NULL
$	NULL
31.0	NULL
Fare	NULL
1p	NULL
*~	NULL
#	NULL
*	NULL
ee	NULL
<	NULL
b	NULL
we	NULL
«	NULL
e	NULL
0	NULL
o	NULL
0	NULL
6	NULL
Gove	NULL
e	NULL
ose	NULL
C	NULL
LAM	NULL
LPS	NULL
_C	NULL
LAM	NULL
LPS	NULL
C	NULL
LAM	NULL
LPS	NULL
C	NULL
L	NULL
1158/+11	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
specific	NULL
,	NULL
because	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
complex	NULL
was	NULL
abolished	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
%	NULL
X	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
wild-type	NULL
NF-ILG6	NULL
probe	NULL
but	NULL
not	NULL
abolished	NULL
by	NULL
competition	NULL
with	NULL
100	NULL
%	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
mutant	NULL
NF-IL6	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
and	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
are	NULL
shown	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
.	NULL

Experiments	NULL
not	NULL
shown	NULL
demonstrated	NULL
similar	NULL
results	NULL
with	NULL
DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
the	NULL
3	NULL
'	NULL
NF-IL6	NULL
probe	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
IL-6	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
upon	NULL
exposure	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
to	NULL
M.	NULL
tuberculosis	NULL
or	NULL
its	NULL
components	NULL
(	NULL
33	NULL
)	NULL
.	NULL

LAM	NULL
purified	NULL
from	NULL
the	NULL
cell	NULL
wall	NULL
and	NULL
live	NULL
M.	NULL
tuberculosis	NULL
appeared	NULL
to	NULL
be	NULL
significant	NULL
enhancers	NULL
of	NULL
IL-6	NULL
expression	NULL
,	NULL
and	NULL
LAM	NULL
and	NULL
LPS	NULL
shared	NULL
common	NULL
mechanisms	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
IL-6	NULL
promoter	NULL
elements	NULL
.	NULL

The	NULL
LAM	NULL
had	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
LPS-free	NULL
and	NULL
LPS	NULL
inhibitors	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
results	NULL
(	NULL
19	NULL
,	NULL
34	NULL
)	NULL
:	NULL
both	NULL
targeted	NULL
inducing	NULL
activity	NULL
on	NULL
NF-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
.	NULL

NF-IL6	NULL
or	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
can	NULL
function	NULL
independently	NULL
in	NULL
response	NULL
to	NULL
LAM	NULL
or	NULL
LPS	NULL
stimulation	NULL
because	NULL
mutation	NULL
of	NULL
either	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
function	NULL
of	NULL
l	NULL
>	NULL
¥-ps	NULL
1-8	NULL
1-BDC-	NULL
AM	NULL
LPS	NULL
LAM	NULL
LPS	NULL
-224/+11	NULL
158/+11	NULL
109/+11	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
15	NULL
«	NULL
s	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
region	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
transiently	NULL
in	NULL
separate	NULL
experiments	NULL
with	NULL
four	NULL
plasmid	NULL
constructs	NULL
containing	NULL
different	NULL
lengths	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
region	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
numbers	NULL
on	NULL
the	NULL
bottom	NULL
.	NULL

Lanes	NULL
C	NULL
,	NULL
49/+1	NULL
control	NULL
.	NULL

the	NULL
other	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
<	NULL
200	NULL
bp	NULL
(	NULL
from	NULL
positions	NULL
-158	NULL
to	NULL
-49	NULL
)	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
contains	NULL
the	NULL
major	NULL
promoter	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
LAM	NULL
or	NULL
LPS	NULL
.	NULL

Within	NULL
this	NULL
fragment	NULL
were	NULL
two	NULL
NF-IL6	NULL
and	NULL
one	NULL
NF-KB	NULL
sites	NULL
,	NULL
all	NULL
demonstrating	NULL
positive	NULL
regulatory	NULL
activities	NULL
,	NULL
although	NULL
the	NULL
5°	NULL
NF-IL6	NULL
was	NULL
demonstrably	NULL
less	NULL
potent	NULL
than	NULL
the	NULL
3	NULL
'	NULL
NF-IL6	NULL
,	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
appeared	NULL
to	NULL
be	NULL
the	NULL
most	NULL
potent	NULL
enhancer	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
mutation	NULL
of	NULL
all	NULL
NF-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
abolished	NULL
IL-6	NULL
promoter	NULL
activity	NULL
after	NULL
incubation	NULL
with	NULL
LAM	NULL
or	NULL
LPS	NULL
.	NULL

LAM	NULL
or	NULL
LPS	NULL
could	NULL
induce	NULL
specific	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
NF-IL6	NULL
wild-type	NULL
target	NULL
sequences	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
LAM-	NULL
or	NULL
LPS-induced	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
IL-6	NULL
regulatory	NULL
region	NULL
mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
IL-6	NULL
.	NULL

This	NULL
report	NULL
also	NULL
demonstrates	NULL
that	NULL
LPS	NULL
from	NULL
Gram-negative	NULL
bacteria	NULL
and	NULL
LAM	NULL
from	NULL
mycobacteria	NULL
function	NULL
through	NULL
similar	NULL
mechanisms	NULL
:	NULL
they	NULL
both	NULL
activate	NULL
NF-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
on	NULL
the	NULL
IL-6	NULL
gene	NULL
.	NULL

We	NULL
propose	NULL
NF-IL6	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
important	NULL
mycobacterial	NULL
or	NULL
bacterial	NULL
response	NULL
elements	NULL
and	NULL
may	NULL
be	NULL
relevant	NULL
to	NULL
other	NULL
host	NULL
cytokines	NULL
.	NULL

Previous	NULL
investigators	NULL
have	NULL
evaluated	NULL
the	NULL
IL-6	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
enhancer/promoter	NULL
sites	NULL
that	NULL
responded	NULL
to	NULL
IL-18	NULL
.	NULL

Ray	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
identified	NULL
a	NULL
115-bp	NULL
fragment	NULL
(	NULL
positions	NULL
-225	NULL
to	NULL
>	NULL
¥s	NULL
¥	NULL
-D-	NULL
1	NULL
-H	NULL
¥-Hf	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

-	NULL
Analysis	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
region	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

The	NULL
schematics	NULL
at	NULL
the	NULL
top	NULL
show	NULL
the	NULL
combinations	NULL
of	NULL
mutations	NULL
.	NULL

The	NULL
X	NULL
marks	NULL
the	NULL
mutated	NULL
motif	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
after	NULL
stimulation	NULL
with	NULL
LAM	NULL
or	NULL
LPS	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Lanes	NULL
C	NULL
,	NULL
control	NULL
.	NULL

Immunology	NULL
:	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
B	NULL
f	NULL
``	NULL
2	NULL
``	NULL
3	NULL
4°	NULL
``	NULL
pq	NULL
a=	NULL
,	NULL
apld	NULL
wit	NULL
wes	NULL
NF-IL-6	NULL
NF-kB	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Induction	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
5	NULL
NF-IL6	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
5	NULL
'	NULL
NF-IL6	NULL
probe	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
unstimulated	NULL
control	NULL
;	NULL
2	NULL
,	NULL
LAM	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
;	NULL
3	NULL
,	NULL
LPS	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
;	NULL
4	NULL
,	NULL
LAM-stimulated	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
authentic	NULL
wild-type	NULL
NF-IL6	NULL
DNA	NULL
;	NULL
5	NULL
,	NULL
LAM-stimulated	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
synthetic	NULL
mutant	NULL
NF-IL6	NULL
sequence	NULL
;	NULL
6	NULL
,	NULL
LPS-stimulated	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
authentic	NULL
wild-type	NULL
NF-IL6	NULL
sequence	NULL
;	NULL
7	NULL
,	NULL
LPS-stimulated	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
synthetic	NULL
mutant	NULL
NF-IL6	NULL
sequence	NULL
(	NULL
5-CCGTACAAT-3	NULL
'	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
unstimulated	NULL
control	NULL
;	NULL
2	NULL
,	NULL
LAM	NULL
stimulation	NULL
;	NULL
3	NULL
,	NULL
LPS	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
;	NULL
4	NULL
,	NULL
LAM-stimulated	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
authentic	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
;	NULL
5	NULL
,	NULL
LAM-stimulated	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
synthetic	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
;	NULL
6	NULL
,	NULL
LPS-stimulated	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
authentic	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
;	NULL
7	NULL
,	NULL
LPS-stimulated	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
synthetic	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
(	NULL
5-CTCATTTTCC-3	NULL
'	NULL
)	NULL
.	NULL

-111	NULL
)	NULL
that	NULL
had	NULL
promoter	NULL
activity	NULL
with	NULL
a	NULL
23-bp	NULL
element	NULL
(	NULL
positions	NULL
-173	NULL
to	NULL
-151	NULL
)	NULL
that	NULL
responded	NULL
to	NULL
multiple	NULL
stimuli	NULL
and	NULL
overlapped	NULL
2	NULL
bp	NULL
of	NULL
our	NULL
5°	NULL
NF-IL6	NULL
site	NULL
.	NULL

However	NULL
,	NULL
Lieberman	NULL
and	NULL
Baltimore	NULL
(	NULL
36	NULL
)	NULL
and	NULL
others	NULL
(	NULL
20	NULL
,	NULL
37	NULL
)	NULL
provided	NULL
convincing	NULL
evidence	NULL
including	NULL
site-directed	NULL
mutagenesis	NULL
that	NULL
a	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
positions	NULL
-73	NULL
to	NULL
-63	NULL
)	NULL
was	NULL
the	NULL
key	NULL
IL-1	NULL
and	NULL
TNF-a	NULL
responsive	NULL
enhancer/promoter	NULL
element	NULL
on	NULL
IL-6	NULL
.	NULL

In-terestingly	NULL
,	NULL
Lieberman	NULL
and	NULL
Baltimore	NULL
(	NULL
36	NULL
)	NULL
stated	NULL
that	NULL
there	NULL
was	NULL
a	NULL
nearby	NULL
unidentified	NULL
sequence	NULL
that	NULL
could	NULL
act	NULL
synergis-tically	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Close	NULL
inspection	NULL
of	NULL
our	NULL
data	NULL
reveals	NULL
synergism	NULL
between	NULL
our	NULL
3	NULL
'	NULL
NF-IL6	NULL
site	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Isshiki	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
identified	NULL
a	NULL
14-bp	NULL
palindromic	NULL
sequence	NULL
that	NULL
overlapped	NULL
our	NULL
5	NULL
NF-IL6	NULL
site	NULL
that	NULL
was	NULL
an	NULL
IL-1	NULL
responsive	NULL
element	NULL
.	NULL

This	NULL
was	NULL
consistent	NULL
with	NULL
our	NULL
data	NULL
demonstrating	NULL
that	NULL
the	NULL
5°	NULL
NF-IL6	NULL
and	NULL
the	NULL
other	NULL
two	NULL
enhancer/promoter	NULL
sequences	NULL
acted	NULL
independent	NULL
of	NULL
each	NULL
other	NULL
and	NULL
orientation	NULL
.	NULL

Akira	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
cloned	NULL
the	NULL
NF-IL6	NULL
gene	NULL
and	NULL
observed	NULL
that	NULL
it	NULL
had	NULL
high	NULL
sequence	NULL
homology	NULL
with	NULL
C/EBP	NULL
,	NULL
a	NULL
family	NULL
of	NULL
rat	NULL
liver	NULL
nuclear	NULL
factors	NULL
.	NULL

They	NULL
noted	NULL
that	NULL
NF-IL6	NULL
bound	NULL
to	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
several	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
acute-phase	NULL
response	NULL
and	NULL
present	NULL
in	NULL
macrophages	NULL
including	NULL
TNF-a	NULL
,	NULL
IL-8	NULL
,	NULL
IL-18	NULL
,	NULL
albumin	NULL
,	NULL
haptoglobin	NULL
,	NULL
granulocyte	NULL
col-ony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
C	NULL
reactive	NULL
protein	NULL
.	NULL

Clinical	NULL
investigations	NULL
of	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
bronchoalveolar	NULL
lavage	NULL
cells	NULL
will	NULL
help	NULL
clarify	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
in	NULL
active	NULL
tuberculosis	NULL
infection	NULL
and	NULL
determine	NULL
whether	NULL
modulating	NULL
IL-6	NULL
has	NULL
a	NULL
role	NULL
in	NULL
assisting	NULL
host	NULL
defense	NULL
mechanisms	NULL
as	NULL
a	NULL
potential	NULL
therapeutic	NULL
strategy	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
2229	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grants	NULL
AI	NULL
30989	NULL
and	NULL
GCRC	NULL
MO1-RRO009Y6	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
the	NULL
Aaron	NULL
Diamond	NULL
Foundation	NULL
.	NULL

1	NULL
.	NULL

Harris	NULL
,	NULL
H.	NULL
W.	NULL
&	NULL
McClement	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
in	NULL
Infectious	NULL
Diseases	NULL
:	NULL
A	NULL
Modern	NULL
Treatise	NULL
of	NULL
Infectious	NULL
Processes	NULL
,	NULL
eds	NULL
.	NULL

Hoeprich	NULL
,	NULL
P.	NULL
&	NULL
Jordan	NULL
,	NULL
M.	NULL
(	NULL
Lippincott	NULL
,	NULL
Philadelphia	NULL
)	NULL
,	NULL
4th	NULL
Ed	NULL
.	NULL

,	NULL
pp	NULL
.	NULL

351-378	NULL
.	NULL

Murray	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

140	NULL
,	NULL
1788-1795	NULL
.	NULL

Ellner	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Wallis	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Rev	NULL
.	NULL

Infect	NULL
.	NULL

Dis	NULL
.	NULL

11	NULL
,	NULL
$	NULL
455-	NULL
$	NULL
459	NULL
.	NULL

Kaufman	NULL
,	NULL
S.	NULL
&	NULL
Flesch	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Springer	NULL
Semin	NULL
.	NULL

Immunopathol	NULL
.	NULL

10	NULL
,	NULL
337-358	NULL
.	NULL
'	NULL

Eliner	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J	NULL
.	NULL

Lab	NULL
.	NULL

Clin	NULL
.	NULL

Med	NULL
.	NULL

108	NULL
,	NULL
142-149	NULL
.	NULL

Kunkel	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Chensue	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Strieter	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Lynch	NULL
,	NULL
J.	NULL
P.	NULL
&	NULL
Remick	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

1	NULL
,	NULL
439-447	NULL
.	NULL

Vilcek	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Lee	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
7313-7316	NULL
.	NULL

Kindler	NULL
,	NULL
V.	NULL
,	NULL
Sappino	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Grau	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Piguet	NULL
,	NULL
P.	NULL
F.	NULL
&	NULL
Vassalli	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
56	NULL
,	NULL
731-740	NULL
.	NULL

9	NULL
.	NULL

Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
1-10	NULL
.	NULL

10	NULL
.	NULL

Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Ann	NULL
.	NULL

N.Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

557	NULL
,	NULL
438-443	NULL
.	NULL

11	NULL
.	NULL

Castell	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
Andus	NULL
,	NULL
T.	NULL
,	NULL
Kunz	NULL
,	NULL
D.	NULL
&	NULL
Heinrich	NULL
,	NULL
P.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Ann	NULL
.	NULL

N.Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

557	NULL
,	NULL
87-101	NULL
.	NULL

12	NULL
.	NULL

Denis	NULL
,	NULL
M.	NULL
&	NULL
Gregg	NULL
,	NULL
E.	NULL
O	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Can	NULL
.	NULL

J.	NULL
Microbiol	NULL
.	NULL

37	NULL
,	NULL
479-483	NULL
.	NULL

13	NULL
.	NULL

Shiratsuchi	NULL
,	NULL
H.	NULL
,	NULL
Johnson	NULL
,	NULL
J.	NULL
L.	NULL
&	NULL
Eliner	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
3165-3170	NULL
.	NULL

14	NULL
.	NULL

-	NULL
Schindler	NULL
,	NULL
R.	NULL
,	NULL
Mancilla	NULL
,	NULL
J.	NULL
,	NULL
Endres	NULL
,	NULL
S.	NULL
,	NULL
Ghorbani	NULL
,	NULL
R.	NULL
,	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
&	NULL
Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Blood	NULL
75	NULL
,	NULL
40-47	NULL
.	NULL

15	NULL
.	NULL

Aderka	NULL
,	NULL
D.	NULL
,	NULL
Le	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Vilcek	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

143	NULL
,	NULL
3517-3523	NULL
.	NULL

16	NULL
.	NULL

Barnes	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
Fong	NULL
,	NULL
S.-J	NULL
.	NULL

,	NULL
Brennan	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Twomey	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
Ma-zumder	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Modlin	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

145	NULL
,	NULL
149-154	NULL
.	NULL

17	NULL
.	NULL

Takashima	NULL
,	NULL
T.	NULL
,	NULL
Ueta	NULL
,	NULL
C.	NULL
,	NULL
Tsuyuguchi	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Kishimoto	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

58	NULL
,	NULL
3286-3292	NULL
.	NULL

18	NULL
.	NULL

Moreno	NULL
,	NULL
C.	NULL
,	NULL
Taverne	NULL
,	NULL
J.	NULL
,	NULL
Mehlert	NULL
,	NULL
A.	NULL
,	NULL
Bate	NULL
,	NULL
C.	NULL
A.	NULL
W.	NULL
,	NULL
Brealey	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Meager	NULL
,	NULL
A.	NULL
,	NULL
Rook	NULL
,	NULL
G.	NULL
A.	NULL
W.	NULL
&	NULL
Playfair	NULL
,	NULL
J.	NULL
H.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

76	NULL
,	NULL
240-245	NULL
.	NULL

19	NULL
.	NULL

Chatterjee	NULL
,	NULL
D.	NULL
,	NULL
Roberts	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Lowell	NULL
,	NULL
K.	NULL
,	NULL
Brennan	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

&	NULL
Orme	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

60	NULL
,	NULL
1249-1253	NULL
.	NULL

20	NULL
.	NULL

Barnes	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
Chatterjee	NULL
,	NULL
D.	NULL
,	NULL
Abrams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Lu	NULL
,	NULL
S.	NULL
,	NULL
Wang	NULL
,	NULL
E.	NULL
,	NULL
Yamamuraa	NULL
,	NULL
M.	NULL
,	NULL
Brennan	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

&	NULL
Modlin	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
541-547	NULL
.	NULL

21	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
Doerfler	NULL
,	NULL
M.	NULL
,	NULL
Lee	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Guillemin	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Rom	NULL
,	NULL
W.	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

91	NULL
,	NULL
2076-2083	NULL
.	NULL

22	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
Lin	NULL
,	NULL
J.	NULL
X	NULL
.	NULL

&	NULL
Vilcek	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
3818-3823	NULL
.	NULL

23	NULL
.	NULL

Edelman	NULL
,	NULL
A.	NULL
S.	NULL
&	NULL
Zolla-Pazner	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

3	NULL
,	NULL
22-30	NULL
.	NULL

24	NULL
.	NULL

Hill	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Premkumar	NULL
,	NULL
S.	NULL
,	NULL
Brustein	NULL
,	NULL
S.	NULL
,	NULL
Vaidya	NULL
,	NULL
K.	NULL
,	NULL
Powell	NULL
,	NULL
S.	NULL
,	NULL
Li	NULL
,	NULL
P.	NULL
W.	NULL
&	NULL
Suster	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

144	NULL
,	NULL
1164-1170	NULL
.	NULL

25	NULL
.	NULL

Bames	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
Bloch	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Davidson	NULL
,	NULL
P.	NULL
T.	NULL
&	NULL
Snider	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

324	NULL
,	NULL
1644-1650	NULL
.	NULL

26	NULL
.	NULL

Daley	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Small	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Schecter	NULL
,	NULL
G.	NULL
F.	NULL
,	NULL
Schoolnik	NULL
,	NULL
G.	NULL
K.	NULL
,	NULL
McAdam	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Phil	NULL
,	NULL
D.	NULL
,	NULL
Jacobs	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Hopewell	NULL
,	NULL
P.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

326	NULL
,	NULL
231-235	NULL
.	NULL

27	NULL
.	NULL

Brennan	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Hunter	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
McNeil	NULL
,	NULL
M.	NULL
,	NULL
Chatterjee	NULL
,	NULL
D.	NULL
&	NULL
Daffe	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Microbial	NULL
Determinants	NULL
of	NULL
Virulence	NULL
and	NULL
Host	NULL
Re-sponse	NULL
,	NULL
eds	NULL
.	NULL

Ayoub	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Cassell	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
Brance	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Henrys	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

(	NULL
Am	NULL
.	NULL

Soc	NULL
.	NULL

Microbiol	NULL
.	NULL

,	NULL
Washington	NULL
,	NULL
DC	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

55-75	NULL
.	NULL

28	NULL
.	NULL

Hunter	NULL
,	NULL
S.	NULL
W.	NULL
&	NULL
Brennan	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
9272-9279	NULL
.	NULL

29	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Shubiya	NULL
,	NULL
H.	NULL
,	NULL
Ohashi	NULL
,	NULL
T.	NULL
,	NULL
Yamanishi	NULL
,	NULL
K.	NULL
&	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
401-407	NULL
.	NULL

30	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
&	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
.	NULL

31	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Rolder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

32	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

33	NULL
.	NULL

Blanchard	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Beatriz	NULL
Michelini-Norris	NULL
,	NULL
M.	NULL
,	NULL
Pearson	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Freitag	NULL
,	NULL
C.	NULL
S.	NULL
&	NULL
Djen	NULL
,	NULL
J.	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
2218-2224	NULL
.	NULL

34	NULL
.	NULL

Valone	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Rich	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Wallis	NULL
,	NULL
R.	NULL
S.	NULL
&	NULL
Eliner	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

56	NULL
,	NULL
3313-3315	NULL
.	NULL

35	NULL
.	NULL

Ray	NULL
,	NULL
A.	NULL
,	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
&	NULL
Sehgal	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5537-5547	NULL
.	NULL

36	NULL
.	NULL

Lieberman	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2327-2334	NULL
.	NULL

37	NULL
.	NULL

Shimizu	NULL
,	NULL
H.	NULL
,	NULL
Mitomo	NULL
,	NULL
K.	NULL
,	NULL
Watanabe	NULL
,	NULL
T.	NULL
,	NULL
Okamoto	NULL
,	NULL
S.	NULL
&	NULL
Yama-moto	NULL
,	NULL
K.-I	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
561-568	NULL
.	NULL

38	NULL
.	NULL

-	NULL
Isshiki	NULL
,	NULL
H.	NULL
,	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Tanabe	NULL
,	NULL
O.	NULL
,	NULL
Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Shimamoto	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
&	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2757-2764	NULL
.	NULL

39	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
Isshiki	NULL
,	NULL
H.	NULL
,	NULL
Sugita	NULL
,	NULL
T.	NULL
,	NULL
Tanabe	NULL
,	NULL
O.	NULL
,	NULL
Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
Nishio	NULL
,	NULL
Y.	NULL
,	NULL
Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
&	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
897-1906	NULL
.	NULL

A	NULL
wb	NULL
on	NULL
gum	NULL

